AEGON ASSET MANAGEMENT UK Plc boosted its stake in The Sherwin-Williams Company (NYSE:SHW - Free Report) by 12.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,247 shares of the specialty chemicals company's stock after acquiring an additional 7,948 shares during the period. AEGON ASSET MANAGEMENT UK Plc's holdings in Sherwin-Williams were worth $25,456,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in SHW. Price T Rowe Associates Inc. MD raised its holdings in shares of Sherwin-Williams by 21.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 8,657,536 shares of the specialty chemicals company's stock worth $3,023,126,000 after purchasing an additional 1,505,341 shares during the period. Nuveen LLC acquired a new stake in shares of Sherwin-Williams during the first quarter worth $265,510,000. Assenagon Asset Management S.A. raised its holdings in shares of Sherwin-Williams by 601.0% during the second quarter. Assenagon Asset Management S.A. now owns 839,756 shares of the specialty chemicals company's stock worth $288,339,000 after purchasing an additional 719,965 shares during the period. National Bank of Canada FI raised its holdings in shares of Sherwin-Williams by 223.1% during the first quarter. National Bank of Canada FI now owns 615,375 shares of the specialty chemicals company's stock worth $214,883,000 after purchasing an additional 424,930 shares during the period. Finally, Alyeska Investment Group L.P. raised its holdings in shares of Sherwin-Williams by 367.9% during the first quarter. Alyeska Investment Group L.P. now owns 537,216 shares of the specialty chemicals company's stock worth $187,590,000 after purchasing an additional 422,410 shares during the period. 77.67% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at Sherwin-Williams
In related news, insider Justin T. Binns sold 609 shares of the stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $368.82, for a total value of $224,611.38. Following the completion of the transaction, the insider owned 17,922 shares in the company, valued at $6,609,992.04. This represents a 3.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CAO James P. Lang sold 860 shares of the stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $350.35, for a total transaction of $301,301.00. Following the completion of the transaction, the chief accounting officer owned 377 shares of the company's stock, valued at $132,081.95. This represents a 69.52% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on SHW. BMO Capital Markets dropped their target price on shares of Sherwin-Williams from $405.00 to $391.00 and set an "outperform" rating on the stock in a report on Wednesday, July 23rd. Weiss Ratings reissued a "buy (b-)" rating on shares of Sherwin-Williams in a report on Wednesday, October 8th. JPMorgan Chase & Co. dropped their target price on shares of Sherwin-Williams from $390.00 to $378.00 and set an "overweight" rating on the stock in a report on Wednesday, July 23rd. Bank of America dropped their target price on shares of Sherwin-Williams from $375.00 to $368.00 and set a "neutral" rating on the stock in a report on Tuesday. Finally, Wells Fargo & Company set a $395.00 price objective on shares of Sherwin-Williams and gave the stock an "overweight" rating in a report on Friday. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $387.13.
Read Our Latest Analysis on SHW
Sherwin-Williams Stock Up 0.9%
SHW stock opened at $335.22 on Wednesday. The company has a quick ratio of 0.48, a current ratio of 0.78 and a debt-to-equity ratio of 1.78. The Sherwin-Williams Company has a fifty-two week low of $308.84 and a fifty-two week high of $400.42. The firm's 50-day simple moving average is $354.37 and its 200 day simple moving average is $348.31. The stock has a market cap of $83.58 billion, a PE ratio of 33.26, a price-to-earnings-growth ratio of 2.76 and a beta of 1.20.
Sherwin-Williams (NYSE:SHW - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The specialty chemicals company reported $3.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.76 by ($0.38). The company had revenue of $6.31 billion during the quarter, compared to the consensus estimate of $6.31 billion. Sherwin-Williams had a net margin of 11.03% and a return on equity of 66.91%. The business's quarterly revenue was up .6% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.70 EPS. Sherwin-Williams has set its FY 2025 guidance at 11.200-11.500 EPS. As a group, sell-side analysts predict that The Sherwin-Williams Company will post 12 EPS for the current year.
About Sherwin-Williams
(
Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.